Article Versions Notes

Tanaka S, Begue F, Veeren B, Tran-Dinh A, Robert T, Tashk P, Lortat-Jacob B, Faille D, de Chaisemartin L, Zappella N, et al. First Recombinant High-Density Lipoprotein Particles Administration in a Severe ICU COVID-19 Patient, a Multi-Omics Exploratory Investigation. Biomedicines. 2022; 10(4):754. https://doi.org/10.3390/biomedicines10040754

Tanaka, Sébastien, Floran Begue, Bryan Veeren, Alexy Tran-Dinh, Tiphaine Robert, Parvine Tashk, Brice Lortat-Jacob, Dorothée Faille, Luc de Chaisemartin, Nathalie Zappella, and et al. 2022. "First Recombinant High-Density Lipoprotein Particles Administration in a Severe ICU COVID-19 Patient, a Multi-Omics Exploratory Investigation" Biomedicines 10, no. 4: 754. https://doi.org/10.3390/biomedicines10040754

Tanaka, S., Begue, F., Veeren, B., Tran-Dinh, A., Robert, T., Tashk, P., Lortat-Jacob, B., Faille, D., de Chaisemartin, L., Zappella, N., Atchade, E., Kramer, L., Montravers, P., & Meilhac, O. (2022). First Recombinant High-Density Lipoprotein Particles Administration in a Severe ICU COVID-19 Patient, a Multi-Omics Exploratory Investigation. Biomedicines, 10(4), 754. https://doi.org/10.3390/biomedicines10040754